Disclosure for Listing Approval received under Preferential Issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Achyut Healthcare Ltd has received listing approval from BSE for issuing 58,00,000 (5.8 million) new equity shares with face value of Re.1 each at an issue price of Rs.6 per share. The shares are being allotted to both Promoters and Non-promoters on a preferential basis. The BSE approval letter (LOD/PREF/SS/FIP/187/2026-27) was received on May 07, 2026. The company must now complete trading approval formalities including NSDL/CDSL confirmation for share crediting and lock-in compliance within seven working days as per SEBI ICDR regulations. A change exceeding 2% in shareholding will require XBRL filing.
This preferential allotment will dilute existing shareholder equity as 5.8 million new shares are being issued, potentially affecting per-share metrics. The issue price of Rs.6 (6x face value) indicates the company is raising capital at a premium, which may be viewed positively if the funds support growth.